Salvatore Calabrese

Insider Reports History

Location
Bethesda, MD
Signature
/s/ Jason Minio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Salvatore Calabrese:

Company Role Class Num Shares Value Price $ Report Date Ownership
Gain Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 50,000 $293,000 $5.86 23 Mar 2023 Direct
Gain Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 25,000 $62,500 $2.50 23 Mar 2023 Direct
Gain Therapeutics, Inc. Chief Financial Officer Common Stock 3,000 $7,380 $2.46 19 May 2022 Direct

Insider Reports Filed by Salvatore Calabrese

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GANX Gain Therapeutics, Inc. 23 Mar 2023 2 $0 4 Chief Financial Officer 27 Mar 2023, 17:28
GANX Gain Therapeutics, Inc. 15 Jul 2022 2 $0 4 Chief Financial Officer 19 Jul 2022, 16:37
GANX Gain Therapeutics, Inc. 19 May 2022 1 $8,100 4/A CHIEF FINANCIAL OFFICER 23 May 2022, 16:00